You have 9 free searches left this month | for more free features.

Condition

Pulmonary Hypertension (2)

Coronavirus Disease 2019 (COVID-19) (1)

Hypertension, Pulmonary (1)

Hypoxemia (1)

Pneumonia (1)

Pulmonary Arterial Hypertension (1)

Overall Status

Recruiting (2)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Merck Sharp & Dohme LLC (4)

Collaborator

Intervention

mk-5475 (4)

placebo (3)

placebo to mk-5475 (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

mk-5475

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pulmonary Hypertension Trial in Lexington (MK-5475, Placebo)

Recruiting

Pulmonary Hypertension

MK-5475
Placebo

Lexington, Kentucky

Lexington VA Medical Center - Cooper Division ( Site 0137)

Jan 8, 2023

Pulmonary Hypertension Trial in Israel, Moldova, Republic of, United States (MK-5475, Placebo)

Completed

Pulmonary Hypertension

MK-5475
Placebo

Lexington, Kentucky
+8 more

Aug 24, 2022

Pulmonary Arterial Hypertension, Hypertension, Pulmonary Trial in Worldwide (MK-5475, Placebo to MK-5475)

Recruiting

Pulmonary Arterial Hypertension
Hypertension, Pulmonary

MK-5475
Placebo to MK-5475

Sacramento, California
+82 more

Jan 19, 2023

Coronavirus Disease 2019 (COVID-19), Pneumonia, Hypoxemia Trial (MK-5475, Placebo)

Withdrawn

Coronavirus Disease 2019 (COVID-19)
+2 more

MK-5475
Placebo

(no location specified)

Aug 12, 2020